Halozyme Therapeutics, Inc.
HALOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Halozyme Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Tidemark, LLC | 2026-03-31 | 288 | $18.6K | SEC filing |
| Arkadios Wealth Advisors | 2026-03-31 | 19,622 | $1.27M | SEC filing |
| State of Wyoming | 2026-03-31 | 7,258 | $469K | SEC filing |
| HANCOCK WHITNEY CORP | 2026-03-31 | 233,542 | $14.9M | SEC filing |
| ARIZONA STATE RETIREMENT SYSTEM | 2026-03-31 | 32,301 | $2.09M | SEC filing |
| Ameritas Advisory Services, LLC | 2026-03-31 | 6,189 | $400K | SEC filing |
| CAMPBELL NEWMAN ASSET MANAGEMENT INC | 2026-03-31 | 36,130 | $2.34M | SEC filing |
| Precision Wealth Strategies, LLC | 2026-03-31 | 7,234 | $468K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 44,486 | $2.88M | SEC filing |
| Sanctuary Advisors, LLC | 2026-03-31 | 12,907 | $834K | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 68,128 | $4.4M | SEC filing |
| Steamboat Capital Partners, LLC | 2026-03-31 | 109,737 | $7.09M | SEC filing |
| YOUSIF CAPITAL MANAGEMENT, LLC | 2026-03-31 | 29,661 | $1.92M | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 6,833 | $442K | SEC filing |
| CX Institutional | 2026-03-31 | 27 | Not shown | SEC filing |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | 2026-03-31 | 25,853 | $1.67M | SEC filing |
| ELEVATION POINT WEALTH PARTNERS, LLC | 2026-03-31 | 3,237 | $209K | SEC filing |
| ALLSTATE CORP | 2026-03-31 | 11,206 | $724K | SEC filing |
| Invesco Ltd. | 2026-03-31 | 4,012,494 | $259M | SEC filing |
| WHITTIER TRUST CO | 2026-03-31 | 270 | $17K | SEC filing |
- Each value is checked against Halozyme Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Halozyme Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Halozyme Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-02 · Torley Helen: Larger than 91 of the 95 other insider sales of Common Stock on file. SEC filing
- 2026-04-02 · Torley Helen: Larger than 89 of the 95 other insider sales of Common Stock on file. SEC filing
- 2026-04-01 · Torley Helen: Larger than 94 of the 95 other insider sales of Common Stock on file. SEC filing
- 2026-03-09 · Caudill Cortney: Larger than 92 of the 95 other insider sales of Common Stock on file. SEC filing
- 2026-03-02 · Torley Helen: Larger than 88 of the 95 other insider sales of Common Stock on file. SEC filing
- 2025-11-10 · Torley Helen: Larger than all 95 other insider sales of Common Stock on file. SEC filing
- 2025-10-03 · Torley Helen: Larger than 86 of the 95 other insider sales of Common Stock on file. SEC filing
- 2025-09-02 · Torley Helen: Larger than 90 of the 95 other insider sales of Common Stock on file. SEC filing
- 2025-08-13 · Torley Helen: Larger than 87 of the 95 other insider sales of Common Stock on file. SEC filing
- 2025-08-11 · Torley Helen: Larger than 93 of the 95 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | Krishnan Mahesh · Director | Common Stock | S — Open market or private sale | −7,304 | 75.00 | SEC filing |
| 2026-06-03 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −6,100 | 69.69 | SEC filing |
| 2026-06-03 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −400 | 66.37 | SEC filing |
| 2026-06-03 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −2,000 | 68.74 | SEC filing |
| 2026-06-03 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −1,500 | 67.68 | SEC filing |
| 2026-06-02 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −3,400 | 66.75 | SEC filing |
| 2026-06-02 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −16,600 | 66.31 | SEC filing |
| 2026-06-01 | Torley Helen · PRESIDENT AND CEO | Common Stock | S — Open market or private sale | −5,401 | 68.35 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-29 | Krishnan Mahesh · Director | Option to Purchase Common Stock | M — Exercise or conversion of derivative security | −7,304 | SEC filing |
| 2026-06-29 | Krishnan Mahesh · Director | Common Stock | M — Exercise or conversion of derivative security | +7,304 | SEC filing |
| 2026-06-12 | Snyder Mark Howard · SVP, CHIEF LEGAL OFFICER | Common Stock | M — Exercise or conversion of derivative security | +5,034 | SEC filing |
| 2026-06-12 | Snyder Mark Howard · SVP, CHIEF LEGAL OFFICER | Restricted Stock Units | M — Exercise or conversion of derivative security | −5,034 | SEC filing |
| 2026-06-12 | Snyder Mark Howard · SVP, CHIEF LEGAL OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −2,715 | SEC filing |
| 2026-06-03 | Torley Helen · PRESIDENT AND CEO | Common Stock | M — Exercise or conversion of derivative security | +10,000 | SEC filing |
| 2026-06-03 | Torley Helen · PRESIDENT AND CEO | Option to Purchase Common Stock | M — Exercise or conversion of derivative security | −10,000 | SEC filing |
| 2026-06-02 | Torley Helen · PRESIDENT AND CEO | Common Stock | M — Exercise or conversion of derivative security | +20,000 | SEC filing |
Showing 8 of 31 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.